Literature DB >> 30146579

A Case of Juvenile Hypertension Suggestive of Adrenomedullary Hyperplasia.

Yoshito Nishimura1, Miho Yasuda1, Kou Hasegawa1, Fumio Otsuka1.   

Abstract

Entities:  

Keywords:  adrenal medullary hyperplasia; hypertension and catecholamines; stroke

Mesh:

Substances:

Year:  2018        PMID: 30146579      PMCID: PMC6378162          DOI: 10.2169/internalmedicine.1182-18

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
A 29-year-old man with a history of cerebellar stroke was referred due to refractory hypertension. His blood pressure was 162/91 mmHg even with doxazosin, nifedipine and cilnidipine. Urinary excretions of catecholamines (adrenaline, 59.1 μg/day; noradrenaline, 1,043.9 μg/day) were elevated. No tumor was detected in the adrenal gland by computed tomography (Picture A, arrowhead) or magnetic resonance imaging (Picture B, arrow). However, 123I-metaiodobenzylguanidine (MIBG) single-photon emission computed tomography (SPECT) revealed the specific uptake in the bilateral adrenal glands with a tumor/liver (T/L) ratio of 1.83 in the left and 2.10 in the right (Picture C, D), findings suggestive of adrenomedullary hyperplasia (AMH). Clonidine failed to reduce the plasma catecholamine levels. AMH is basically stable under α-blocker treatment but is considered to be a preclinical condition of pheochromocytoma (1). Due to the high sensitivity of 123I-MIBG SPECT, we were able to detect false-positive AMH; however, combining imaging findings with the T/L ratio may improve the diagnostic performance (2). AMH should be considered as a differential diagnosis of refractory juvenile hypertension.
Picture.

The authors state that they have no Conflict of Interest (COI).
  2 in total

1.  Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.

Authors:  Anouk van Berkel; Jyotsna U Rao; Jacques W M Lenders; Natalia S Pellegata; Benno Kusters; Ianthe Piscaer; Ad R M M Hermus; Theo S Plantinga; Johan F Langenhuijsen; Dennis Vriens; Marcel J R Janssen; Martin Gotthardt; Henri J L M Timmers
Journal:  J Nucl Med       Date:  2015-04-16       Impact factor: 10.057

2.  Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndrome.

Authors:  Esther Korpershoek; Bart-Jeroen Petri; Edward Post; Casper H J van Eijck; Rogier A Oldenburg; Eric J T Belt; Wouter W de Herder; Ronald R de Krijger; Winand N M Dinjens
Journal:  Neoplasia       Date:  2014-10-23       Impact factor: 5.715

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.